2023-07-07 13:19:47
Title: Japanese Researchers Develop Potential Drug to Treat Genetic Tooth Disorder
Date: July 7, 2023
Japanese researchers are working on a groundbreaking drug that could potentially treat a rare genetic disorder that prevents teeth from growing. The innovative drug aims to offer hope to individuals suffering from anodontia, a condition characterized by the absence of adult teeth.
While animals like sharks and certain reptile species can regrow their teeth continuously, humans are limited in their ability to do so. Typically, humans develop two sets of teeth in their lifetime – milk teeth and permanent teeth. However, these teeth do not always last until the end of life, often requiring extraction and dependence on dentures.
Addressing this issue, Japanese scientists have turned their attention to developing a drug that can facilitate the growth of third-generation teeth. This promising development has paved the way for a clinical trial scheduled for July 2024, as reported by Japan’s national daily, Mainichi.
Dr. Katsu Takahashi, the principal investigator and head of the Department of Dentistry and Maxillofacial Surgery at the Medical Research Institute Kitano Hospital, has been researching this groundbreaking treatment since 2005. Dr. Takahashi expressed his enthusiasm, stating, “The idea of growing new teeth is every dentist’s dream.”
Anodontia, caused by a genetic mutation, hampers the development of tooth germs for both deciduous and permanent teeth. People with this disorder, known as partial anodontia when only a few teeth are missing, face challenges from an early age, such as difficulties in chewing, swallowing, and speaking, which can negatively impact their overall development.
The researchers have identified the USAG-1 gene as a potential solution to this disorder. Dr. Takahashi and his team found that suppressing the USAG-1 gene encourages tooth growth, according to a 2021 study published in Science Advances. Subsequently, they have been working on developing a “neutralizing antibody drug” that can block USAG-1.
In tests conducted on mice and ferrets, the scientists discovered that these animals were able to regrow their teeth after blocking the USAG-1 gene. Building upon these promising results, the researchers aim to make the drug available for children aged 2 to 6 who display signs of anodontia after the necessary tests are completed. The goal is to make the drug accessible for public use by 2030.
If successful, this innovative drug will be the first of its kind worldwide, offering patients the chance to regrow their teeth. This breakthrough could revolutionize dental care and provide much-needed relief for individuals suffering from this genetic disorder.
The scientific community eagerly awaits further updates on this research, which shows immense promise in transforming the lives of individuals with anodontia.]
#Teeth #grow #drug #Science